324769-06-4

Basic information

• Product Name: 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYL-4-OXOPIPERIDINE
• Synonyms: 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYL-4-OXOPIPERIDINE;tert-butyl 3,3-dimethyl-4-oxopiperidine-1-carboxylate;1-Piperidinecarboxylic acid, 3,3-diMethyl-4-oxo-, 1,1-diMethylethyl ester;1,1-Dimethylethyl 3,3-dimethyl-4-oxo-1-piperidinecarboxylate;1-tert-Butoxycarbonyl-3,3-dimethyl-4-piperidone;1-tert-Butyloxycarbonyl-3,3-dimethyl-4-piperidone;3,3-Dimethyl-4-oxo-1-piperidinecarboxylic acid tert-butyl ester;tert-butyl 3,3-diMethyl-4-oxopiperidine-1-carb
• CAS NO: 324769-06-4
• Molecular Formula: C₁₂H₂₁NO₃
• Molecular Weight: 227.31
• Mol File: 324769-06-4.mol
• Article Data: 39

Chemical Properties

• Boiling Point: 303℃
• Flash Point: 137℃
• Appearance: /
• Density: 1.035
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.467
• Storage Temp.: 2-8°C
• PKA: -1.51±0.40(Predicted)
• CAS DataBase Reference: 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYL-4-OXOPIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYL-4-OXOPIPERIDINE(324769-06-4)
• EPA Substance Registry System: 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYL-4-OXOPIPERIDINE(324769-06-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 324769-06-4(Hazardous Substances Data)

Usage

General Description

1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYL-4-OXOPIPERIDINE is a complex organic compound typically used in a laboratory setting due to its specific chemical properties. 1-(TERT-BUTOXYCARBONYL)-3,3-DIMETHYL-4-OXOPIPERIDINE, as its name suggests, consists of a piperidine ring, which is a saturated heterocyclic molecule. Considered a derivative of piperidine, this chemical includes additional functional groups such as a tert-butoxycarbonyl and a dimethyl group. Moreover, it also has a ketone functional group, indicated by the 4-oxo segment of the name. There is limited publicly available information regarding the specific applications or safety measures for this compound, which suggests its use is likely specialized and requires expert handling and knowledge.

InChI:InChI=1/C12H21NO3/c1-11(2,3)16-10(15)13-7-6-9(14)12(4,5)8-13/h6-8H2,1-5H3

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 173186-91-9 N-benzyl-3,3-dimethylpiperidine-4-one 
• 150668-82-9 3,3-Dimethyl-piperidin-4-one 
• 31648-35-8 1-benzyl-3,3-dimethyl-2,4-piperidinedione 
• 324769-02-0 (rac)-1-Benzyl-3,3-dimethyl-piperidin-4-ol 
• 74-88-4 methyl iodide 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 563-80-4 3-methyl-butan-2-one 
• 34737-89-8 1-Benzyl-3-methyl-4-piperidon 

Downstream Products

• 1242240-00-1 tert-butyl 3,3-dimethyl-4-(methylamino)piperidine-1-carboxylate 
• 1415740-89-4 1'-(tert-butoxycarbonyl)-3',3'-dimethyl-1,4'-bipiperidine-4-carboxylic acid 
• 1365155-32-3 tert-butyl 4-(4-methoxybenzylamino)-3,3-dimethylpiperidine-1-carboxylate 
• 1338240-94-0 5-(2,6-dimethoxybenzylidene)-3,3-dimethylpiperidin-4-one 
• 1338240-90-6 5-(3-methoxybenzylidene)-3,3-dimethylpiperidin-4-one 
• 1338240-89-3 5-benzylidene-3,3-dimethylpiperidin-4-one 
• 1338240-95-1 5-(3,4,5-trimethoxybenzylidene)-3,3-dimethylpiperidin-4-one 
• 1338240-92-8 5-(2-chlorobenzylidene)-3,3-dimethylpiperidin-4-one 
• 1338240-93-9 5-(4-chlorobenzylidene)-3,3-dimethylpiperidin-4-one 
• 1338240-96-2 5-(4-fluorobenzylidene)-3,3-dimethylpiperidin-4-one 
• 1338240-99-5 5-(5-bromo-2-methylbenzylidene)-3,3-dimethylpiperidin-4-one 
• 941815-08-3 C₁₉H₂₄Cl₂N₄O₄S 
• 941815-68-5 C₂₅H₃₆N₄O₄S 
• 941815-67-4 C₂₄H₃₄N₄O₄S 

Relevant articles and documents

Protein Modification at Tyrosine with Iminoxyl Radicals

Post-translational modifications (PTMs) of proteins are a biological mechanism for reversibly controlling protein function. Synthetic protein modifications (SPMs) at specific canonical amino acids can mimic PTMs. However, reversible SPMs at hydrophobic amino acid residues in proteins are especially limited. Here, we report a tyrosine (Tyr)-selective SPM utilizing persistent iminoxyl radicals, which are readily generated from sterically hindered oximes via single-electron oxidation. The reactivity of iminoxyl radicals with Tyr was dependent on the steric and electronic demands of oximes; isopropyl methyl piperidinium oxime 1f formed stable adducts, whereas the reaction of tert-butyl methyl piperidinium oxime 1o was reversible. The difference in reversibility between 1f and 1o, differentiated only by one methyl group, is due to the stability of iminoxyl radicals, which is partly dictated by the bond dissociation energy of oxime O-H groups. The Tyr-selective modifications with 1f and 1o proceeded under physiologically relevant, mild conditions. Specifically, the stable Tyr-modification with 1f introduced functional small molecules, including an azobenzene photoswitch, to proteins. Moreover, masking critical Tyr residues by SPM with 1o, and subsequent deconjugation triggered by the treatment with a thiol, enabled on-demand control of protein functions. We applied this reversible Tyr modification with 1o to alter an enzymatic activity and the binding affinity of a monoclonal antibody with an antigen upon modification/deconjugation. The on-demand ON/OFF switch of protein functions through Tyr-selective and reversible covalent-bond formation will provide unique opportunities in biological research and therapeutics.

5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them

The disclosure relates particularly to certain carboxamide, sulfonamide and amine compounds and pharmaceutical compositions thereof, and to methods of treating and ameliorating disorders and conditions related to the adiponectin pathway, sphingolipid metabolism, oxidative stress, mitochondrial dysfunction, free radical damage and metabolic inefficiency, among others. In certain embodiments, the compounds have the structures (I-1), (2-I) and (3-I) in which the variables are as described herein.

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

The invention provides compounds having the general formula I, and pharmaceutically acceptable salts thereof, wherein the variables RA, RAA, subscript n, ring A, X2, L, subscript m, X1, R1, R2, R3, R4, R5, and RN have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.